Inequities Associated With Advanced Stage at Presentation of Head and Neck Cancer

被引:2
|
作者
Ioerger, Patrick [1 ]
Mills, Kale [2 ]
Wagoner, Sarah F. [3 ]
Lawrence, Amelia [3 ]
Alapati, Rahul [3 ]
Nallani, Rohit [3 ]
Hamill, Chelsea S. [3 ]
Boakye, Eric Adjei [4 ,5 ]
Sykes, Kevin J. [1 ,6 ]
机构
[1] Univ Kansas, Sch Med, Kansas City, MO USA
[2] Univ Kansas, Sch Med Wichita, Wichita, KS USA
[3] Univ Kansas Med Ctr, 3901 Rainbow Blvd,Mailstop 3010, Kansas City, KS 66160 USA
[4] Henry Ford Hlth, Dept Publ Hlth Sci, Detroit, MI USA
[5] Henry Ford Hlth, Dept Otolaryngol Head & Neck Surg, Detroit, MI USA
[6] Baylor Scott & White Hlth & Wellness Ctr, Dallas, TX USA
关键词
SQUAMOUS-CELL CARCINOMA; LARYNGEAL-CANCER; RACIAL DISPARITIES; SURVIVAL OUTCOMES; DIAGNOSIS; IMPACT; DETERMINANTS; METASTASIS; DELAYS; RISK;
D O I
10.1001/jamaoto.2024.1180
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Importance Social determinants of health (SDoH) are defined by a wide range of factors (eg, built environment, economic stability, education level, discrimination, racism, access to health care). Advanced stage at presentation or delayed diagnosis heavily influences health outcomes in patients with head and neck cancer (HNC). While the drivers of advanced-stage presentation come from a multitude of sources, SDoH plays an outsized role. Objective To systematically review the published literature to identify which SDoH are established as risk factors for delayed diagnosis or advanced stage at presentation among patients with HNC. Evidence Review In this systematic review, a literature search of PubMed, Web of Science, and Embase was conducted on February 27, 2023, using keywords related to advanced stage at presentation and delayed diagnosis of HNC between 2013 and 2023. Quality assessment was evaluated through the Newcastle-Ottawa Scale. Articles were included if they focused on US-based populations and factors associated with advanced stage at presentation or delayed diagnosis of HNC. Findings Overall, 50 articles were included for full-text extraction, of which 30 (60%) were database studies. Race was the most commonly reported variable (46 studies [92%]), with Black race (43 studies [93%]) being the most studied racial group showing an increased risk of delay in diagnosis of HNC. Other commonly studied variables that were associated with advanced stage at presentation included sex and gender (41 studies [82%]), insurance status (25 studies [50%]), geographic region (5 studies [10%]), and socioeconomic status (20 studies [40%]). Male sex, lack of insurance, rurality, and low socioeconomic status were all identified as risk factors for advanced stage at presentation. Conclusions and Relevance This systematic review provides a comprehensive list of factors that were associated with advanced HNC stage at presentation. Future studies should focus on evaluating interventions aimed at addressing the SDoH in communities experiencing disparities to provide a net positive effect on HNC care.
引用
收藏
页码:727 / 740
页数:14
相关论文
共 50 条
  • [21] Is a planned neck dissection necessary after chemoradiotherapy in head and neck cancer patients with advanced nodal stage
    Soltys, SG
    Suen, A
    Fee, W
    Pinto, H
    Sivanandan, R
    Goode, R
    Goffinet, D
    Le, Q
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S495 - S495
  • [22] Spatially fractionated GRID radiation treatment of advanced neck disease associated with head and neck cancer
    Huhn, JL
    Regine, WF
    Valentino, J
    Meigooni, AS
    Kudrimoti, M
    Kenady, D
    Sloan, D
    Spring, P
    Mohiuddin, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S513 - S513
  • [23] Spatially fractionated GRID radiation treatment of advanced neck disease associated with head and neck cancer
    Huhn, Jeniffer L.
    Regine, William F.
    Valentino, Joseph P.
    Meigooni, Ali S.
    Kudrimoti, Mahesh
    Mohiuddin, Mohammed
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2006, 5 (06) : 607 - 612
  • [24] Increasing incidence of advanced stage head and neck tumours
    Brouha, XDR
    Tromp, DM
    De Leeuw, JRJ
    Hordijk, GJ
    Winnubst, JAM
    CLINICAL OTOLARYNGOLOGY, 2003, 28 (03) : 231 - 234
  • [25] Resection of advanced head and neck cancer and cerebrovascular surgery can be combined in a single stage
    Lewis, DM
    Lamont, J
    Garrett, WV
    Shutze, WP
    Livingston, SA
    O'Brien, JC
    ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (02) : S93 - S93
  • [26] Development of distant metastasis after treatment of advanced-stage head and neck cancer
    Alvi, A
    Johnson, JT
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1997, 19 (06): : 500 - 505
  • [27] MULTIMODALITY PREOPERATIVE TREATMENT FOR ADVANCED STAGE-IV (MO) CANCER OF THE HEAD AND NECK
    MOHITTABATABAI, MA
    HILL, GJ
    RAINA, S
    RUSH, BF
    OHANIAN, M
    AMERICAN JOURNAL OF SURGERY, 1990, 160 (04): : 370 - 372
  • [28] Health insurance status, stage at presentation and survival among female patients with head and neck cancer
    Panth, Neelima
    Simpson, Matthew C.
    Sethi, Rosh K. V.
    Varvares, Mark A.
    Osazuwa-Peters, Nosayaba
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (06)
  • [29] Treatment of early stage head and neck cancer
    Ballmaier, Jonas
    Bitter, Thomas
    Kuhnt, Thomas
    Guntinas-Lichius, Orlando
    ONKOLOGIE, 2023, 29 (09): : 819 - 826
  • [30] Head and neck cancer associated with esophageal cancer
    Watanabe, Akihito
    Hosokawa, Masao
    Taniguchi, Masanobu
    Tsujie, Hitoshi
    Sasaki, Shigeyuki
    AURIS NASUS LARYNX, 2007, 34 (02) : 207 - 211